🔎 Trials Near Me

Utama › Diabetes Jenis 2 › Wilayah Columbia › Washington

Kajian klinikal Diabetes Jenis 2 di Washington, DC

12 kajian untuk Diabetes Jenis 2 sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

The RESET System Pivotal Clinical Trial (Protocol Revision H)

Mengambil peserta
  • MedStar Health Research Institute, Washington D.C.
Umur 22 hingga 65 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT04101669

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Flourish Bowie dba Flourish Research, Bowie · 17 mi jauh
Umur 55 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06112418

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Mengambil pesertaFasa 3
  • Research Site, Beltsville · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07776509

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Mengambil pesertaFasa 3
  • Research Site, Lanham · 11 mi jauh
  • Research Site, Beltsville · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07784270

Plant-Based Online Weight Loss Through Education and Resources Program and Study

Mengambil peserta
  • Physicians Committee for Responsible Medicine, Washington D.C.
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07095543

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Children's National Hospital (CNH), Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Umur 12 hingga 25 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06730113

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Mengambil pesertaFasa 3
  • AURORA-2 Clinical Site, Washington D.C.
  • AURORA-2 Clinical Site, Bowie · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Mengambil pesertaFasa 2
  • Privia Medical Group, LLC - Kelly's Collaborative Care - Javara - PPDS, Silver Spring · 7 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Mengambil pesertaFasa 3
  • Emerson Clinical Research Institute, Washington D.C.
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07351058

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Mengambil pesertaFasa 3
  • Research Site, Bowie · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT07662044

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Mengambil pesertaFasa 3
  • Emerson Clinical Research Institute, Washington D.C.
  • Children's National Medical Center, Washington D.C.
Umur 10 hingga 17 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06739122

Diabetes Reversal Online Program and Study (DROP Study)

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Physician Committee for Responsible Medicine, Washington D.C.
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Apr 2024 · NCT05572502

Kajian Diabetes Jenis 2 di bandar lain

Kajian lain di Washington

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.